- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03423654
Spatial Cognitive Training (SCTVI)
June 4, 2020 updated by: VA Office of Research and Development
Spatial Cognitive Training in Visual Impairment
This study is designed to see if doing regular training on a spatial imagery task leads to improvements in the ability to do the trained spatial imagery task and in the ability to get around in everyday activities.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The investigators will recruit 40 blind participants, randomized by the investigators' CVNR statistician into two groups.
One group will undergo the experimental intervention (spatial cognitive training) and the other will undergo a control intervention involving letter-number matching.
The participants will include women and minorities in proportion to the demographics of the Veteran population attending the Atlanta VA.
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30307
- Emory University
-
Decatur, Georgia, United States, 30033
- Atlanta VA Medical and Rehab Center, Decatur, GA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Inability to perceive visual stimuli, i.e. no light perception, with stable visual loss over the past year
The investigators anticipate that causes of blindness will be ocular, including:
- glaucoma
- diabetic retinopathy and macular degeneration
- the most common causes of blindness in Veterans
- as well as possibly late-onset Leber's optic atrophy and ocular trauma (in the absence of TBI)
- To minimize heterogeneity due to variations in age and the duration of visual loss, the investigators will restrict enrollment to Veterans and Non-Veterans over the age of 50 who lost light perception within the last 5 years, and who have completed standard O&M training.
- From a practical standpoint, this also enables the investigators to focus on participants who can potentially benefit most from the proposed intervention.
Exclusion Criteria:
Participants will be excluded if they have any neurological condition, such as:
- TBI
- history of blast exposure
- stroke
- brain tumors
- epilepsy, etc.
Participants will also be excluded if MRI scanning is contra-indicated, e.g.:
- due to an implanted device such as a pacemaker
- or foreign bodies of ferromagnetic nature
- Cognitive screening will be performed using the Repeatable Battery for Assessment of Neuropsychological Status (RBANS, Randolph, 1998) and participants with cognitive impairment will be excluded based on a score of 1.5 SD below the mean for the Verbal Memory Index.
- The investigators will test participants' hearing using a validated screening questionnaire (Screening Version of the Hearing Handicap Inventory for the Elderly, HHIE-S, Wentry & Weinstein, 1983, Lichtenstein et al., 1988) followed by assessment of audiometric pure tone (0.5, 1.0, 2.0, 4.0 KHz) hearing thresholds in the CVNR sound booth.
- Participants with more than mild hearing loss (HHIE score >8 or audiometric thresholds >40dB) will be excluded (Wentry & Weinstein, 1983; Wilson, 2009), given that the investigators are relying on audio cues.
- The investigators will also exclude visually impaired Veterans who are dependent on a wheelchair or scooter for mobility, as they will not be able to take part in the real-world task.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Training Group
Spatial training
|
Spatial Training using a 5x5 grid
|
|
Other: Control Group
Letter number matching
|
Letter number matching
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spatial Ability
Time Frame: 1 month
|
Ability to orient to where participants began at the beginning of task.
Using a 5x5 grid on testing device, a 5x5 grid that the participant will have to walk, and a 5x5 grid during task in MRI.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: April Y. Maa, MD BS, Atlanta VA Medical and Rehab Center, Decatur, GA
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2018
Primary Completion (Actual)
June 30, 2019
Study Completion (Actual)
June 30, 2019
Study Registration Dates
First Submitted
January 23, 2018
First Submitted That Met QC Criteria
January 30, 2018
First Posted (Actual)
February 6, 2018
Study Record Updates
Last Update Posted (Actual)
June 18, 2020
Last Update Submitted That Met QC Criteria
June 4, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- C2243-P
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blind
-
Wicab Technologies (Beijing) Co., Ltd.Completed
-
Diakonie-Klinikum StuttgartUniversity Hospital TuebingenRecruitingRandomized | Prospective | Double-blindGermany
-
Cumhuriyet UniversityAksaray UniversityRecruitingSmoking | Health Risk Behaviors | Blind EyeTurkey
-
The Hong Kong Polytechnic UniversityCompletedElderly | Mood | Music Therapy | Mindfulness | BlindHong Kong
-
Lone Graff StensballeHvidovre University Hospital; Kolding Sygehus; Danish National Research Foundation and other collaboratorsCompletedProspective | Single-blind | Clinical | Trial | InterventionDenmark
-
Center for Disease Control and Prevention, Henan...UnknownRandomized | Double-blind | Placebo Control Design
-
National Institute of Neurological Disorders and...Completed
-
Massachusetts Eye and Ear InfirmaryNational Eye Institute (NEI)CompletedOne Eye Blindness | Blind Left Eye | Blind Right EyeUnited States
-
Erasme University HospitalBrussel Medical Device Center (BMDC)RecruitingBlind Loop Syndrome Postoperative | Candy Cane SyndromeBelgium
-
Massachusetts Eye and Ear InfirmaryNational Eye Institute (NEI)TerminatedOne Eye Blindness | Blind Left Eye | Blind Right EyeUnited States
Clinical Trials on Spatial Training
-
Albert Einstein College of MedicineNational Institute on Aging (NIA)Not yet recruitingMild Cognitive Impairment (MCI)United States
-
University of PittsburghJohns Hopkins UniversityWithdrawnCognitive Training | Vestibular Abnormality
-
Centre Hospitalier Universitaire de la RéunionCompletedHearing Loss, CochlearRéunion
-
Abant Izzet Baysal UniversityCompletedEducational ProblemsTurkey (Türkiye)
-
University of British ColumbiaUniversity Health Network, TorontoRecruitingTraumatic Brain Injury | Degeneration | Memory; Loss, Mild, Following Organic Brain DamageCanada
-
Sheba Medical CenterBar-Ilan University, IsraelUnknown
-
Imperial College LondonRecruitingHearing Loss | Aminoglycoside Toxicity | Video Games | Aminoglycoside-Induced Hearing LossUnited Kingdom
-
Hospices Civils de LyonRecruiting
-
The University of Texas Health Science Center at...United States Department of DefenseRecruiting
-
Rambam Health Care CampusCompleted